Neumann JE, Spohn M, Obrecht D et al (2020) Molecular characterization of histopathological ependymoma variants. Acta Neuropathol 139(2):305–318. https://doi.org/10.1007/s00401-019-02090-0

Article  CAS  PubMed  Google Scholar 

Celano E, Salehani A, Malcolm JG et al (2016) Spinal cord ependymoma: a review of the literature and case series of ten patients. J Neurooncol 128(3):377–386. https://doi.org/10.1007/s11060-016-2135-8

Article  PubMed  PubMed Central  Google Scholar 

Zhang Q, Cheng S, Wang Y et al (2021) Interrogation of the microenvironmental landscape in spinal ependymomas reveals dual functions of tumor-associated macrophages. Nat Commun 12(1):6867. https://doi.org/10.1038/s41467-021-27018-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Servidei T, Meco D, Martini M et al (2021) The BET inhibitor OTX015 exhibits in vitro and in vivo antitumor activity in pediatric ependymoma stem cell models. Int J Mol Sci 22(4):1877. https://doi.org/10.3390/ijms22041877

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mack SC, Pajtler KW, Chavez L et al (2018) Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature 553(7686):101–105. https://doi.org/10.1038/nature25169

Article  CAS  PubMed  Google Scholar 

de Bont JM, Kros JM, Passier MM et al (2008) Differential expression and prognostic significance of SOX genes in pediatric medulloblastoma and ependymoma identified by microarray analysis. Neuro Oncol 10(5):648–660. https://doi.org/10.1215/15228517-2008-032

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu Z, Mesci P, Bernatchez JA et al (2020) Zika virus targets glioblastoma stem cells through a SOX2-integrin alpha(v)beta(5) axis. Cell Stem Cell 26(2):187–204. https://doi.org/10.1016/j.stem.2019.11.016

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen H, Zhan M, Zhang Y et al (2018) PLZF inhibits proliferation and metastasis of gallbladder cancer by regulating IFIT2. Cell Death Dis 9(2):71. https://doi.org/10.1038/s41419-017-0107-3

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sugiaman-Trapman D, Vitezic M, Jouhilahti EM et al (2018) Characterization of the human RFX transcription factor family by regulatory and target gene analysis. BMC Genomics 19(1):181. https://doi.org/10.1186/s12864-018-4564-6

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jeong HY, Kim HJ, Kim CE et al (2021) High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma. Int J Neurosci 131(1):7–14. https://doi.org/10.1080/00207454.2020.1732969

Article  CAS  PubMed  Google Scholar 

Zheng JJ, He Y, Liu Y et al (2020) Novel role of PAF1 in attenuating radiosensitivity in cervical cancer by inhibiting IER5 transcription. Radiat Oncol 15(1):131. https://doi.org/10.1186/s13014-020-01580-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131(6):803–820. https://doi.org/10.1007/s00401-016-1545-1

Article  PubMed  Google Scholar 

Hsu W, Siu IM, Pradilla G et al (2012) Animal model of intramedullary spinal cord glioma using human glioblastoma multiforme neurospheres. J Neurosurg Spine 16(3):315–319. https://doi.org/10.3171/2011.11.SPINE11492

Article  PubMed  Google Scholar 

Ruda R, Bruno F, Pellerino A et al (2022) Ependymoma: evaluation and management updates. Curr Oncol Rep 24(8):985–993. https://doi.org/10.1007/s11912-022-01260-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ruda R, Reifenberger G, Frappaz D et al (2018) EANO guidelines for the diagnosis and treatment of ependymal tumors. Neuro Oncol 20(4):445–456. https://doi.org/10.1093/neuonc/nox166

Article  PubMed  Google Scholar 

Nicolis SK (2007) Cancer stem cells and stemness genes in neuro-oncology. Neurobiol Dis 25(2):217–229. https://doi.org/10.1016/j.nbd.2006.08.022

Article  CAS  PubMed  Google Scholar 

Arabzade A, Zhao Y, Varadharajan S et al (2021) ZFTA-RELA Dictates oncogenic transcriptional programs to drive aggressive supratentorial ependymoma. Cancer Discov 11(9):2200–2215. https://doi.org/10.1158/2159-8290.CD-20-1066

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zheng W, Zhang S, Guo H et al (2021) Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma. Cell Commun Signal 19(1):39. https://doi.org/10.1186/s12964-021-00728-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wheeler HE, Gamazon ER, Wing C et al (2013) Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of paclitaxel-induced sensory peripheral neuropathy. Clin Cancer Res 19(2):491–499. https://doi.org/10.1158/1078-0432.CCR-12-2618

Article  CAS  PubMed  Google Scholar 

Yu L, Baxter PA, Voicu H et al (2010) A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo. Neuro Oncol 12(6):580–594. https://doi.org/10.1093/neuonc/nop056

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ludwig K, Kornblum HI (2017) Molecular markers in glioma. J Neurooncol 134(3):505–512. https://doi.org/10.1007/s11060-017-2379-y

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malgulwar PB, Nambirajan A, Pathak P et al (2018) C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin. J Neurooncol 138(1):29–39. https://doi.org/10.1007/s11060-018-2767-y

Article  CAS  PubMed  Google Scholar 

Wang M, Ji C, Zhang Y et al (2022) Global changes in chromatin accessibility and transcription in growth hormone-secreting pituitary adenoma. Endocrine 78(2):329–342. https://doi.org/10.1007/s12020-022-03155-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hamilton DW, Lusher ME, Lindsey JC et al (2005) Epigenetic inactivation of the RASSF1A tumour suppressor gene in ependymoma. Cancer Lett 227(1):75–81. https://doi.org/10.1016/j.canlet.2004.11.044

Article  CAS  PubMed  Google Scholar 

Michalowski MB, de Fraipont F, Michelland S et al (2006) Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. Cancer Genet Cytogenet 166(1):74–81. https://doi.org/10.1016/j.cancergencyto.2005.09.004

Article  CAS  PubMed  Google Scholar 

Jiang B, Murray C, Cole BL et al (2022) Mutations of the DNA repair gene PNKP in a patient with microcephaly, seizures, and developmental delay (MCSZ) presenting with a high-grade brain tumor. Sci Rep 12(1):5386. https://doi.org/10.1038/s41598-022-09097-w

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nimmakayala RK, Seshacharyulu P, Lakshmanan I et al (2018) Cigarette smoke induces stem cell features of pancreatic cancer cells via PAF1. Gastroenterology 155(3):892-908e896. https://doi.org/10.1053/j.gastro.2018.05.041

Article  CAS  PubMed  Google Scholar 

Karmakar S, Dey P, Vaz AP et al (2018) PD2/PAF1 at the crossroads of the cancer network. Cancer Res 78(2):313–319. https://doi.org/10.1158/0008-5472.CAN-17-2175

Article  CAS  PubMed  PubMed Central  Google Scholar 

Karmakar S, Rauth S, Nallasamy P et al (2020) RNA polymerase II-associated factor 1 regulates stem cell features of pancreatic cancer cells, independently of the PAF1 complex, via interactions with PHF5A and DDX3. Gastroenterology 159(5):1898-1915e1896. https://doi.org/10.1053/j.gastro.2020.07.053

Article  CAS  PubMed  Google Scholar 

Vaz AP, Ponnusamy MP, Rachagani S et al (2014) Novel role of pancreatic differentiation 2 in facilitating self-renewal and drug resistance of pancreatic cancer stem cells. Br J Cancer 111(3):486–496. https://doi.org/10.1038/bjc.2014.152

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hsu YC, Kao CY, Chung YF et al (2012) Ciliogenic RFX transcription factors regulate FGF1 gene promoter. J Cell Biochem 113(7):2511–2522. https://doi.org/10.1002/jcb.24127

Article  CAS  PubMed  Google Scholar 

Lotsch D, Kirchhofer D, Englinger B et al (2021) Targeting fibroblast growth factor receptors to combat aggressive ependymoma. Acta Neuropathol 142(2):339–360.